We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$29.9B
AUM Growth
+$528M
Cap. Flow
+$375M
Cap. Flow %
1.25%
Top 10 Hldgs %
21.6%
Holding
3,654
New
245
Increased
1,618
Reduced
1,517
Closed
194

Top Buys

Rank Stock Value
1
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$103M
2
BNDX icon
Vanguard Total International Bond ETF
BNDX
+$48.8M
3
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$34.5M
4
JEPQ icon
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
+$34.2M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$26.2M

Top Sells

Rank Stock Value
1
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$39.2M
2
AAPL icon
Apple
AAPL
+$32.9M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$25M
4
VDC icon
Vanguard Consumer Staples ETF
VDC
+$23.8M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 12.16%
2 Financials 5.04%
3 Consumer Discretionary 4.21%
4 Healthcare 2.85%
5 Communication Services 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASRT
3426
DELISTED
Assertio
ASRT
$18K ﹤0.01%
1,345
-1,188
-47% -$17.7K
CGEN icon
3427
Compugen
CGEN
$236M
$18K ﹤0.01%
+11,525
New +$18.7K
ATAI icon
3428
AtaiBeckley Inc
ATAI
$2.68B
$17K ﹤0.01%
13,020
-25
-0.2% -$33
LXRX icon
3429
Lexicon Pharmaceuticals
LXRX
$1.05B
$17K ﹤0.01%
+23,613
New +$28.5K
PZG icon
3430
Paramount Gold Nevada
PZG
$130M
$17K ﹤0.01%
50,627
-48,420
-49% -$18.8K
HRTX icon
3431
Heron Therapeutics
HRTX
$64.7M
$16K ﹤0.01%
10,367
-1,300
-11% -$2.11K
PRPL icon
3432
Purple Innovation
PRPL
$28.4M
$16K ﹤0.01%
798
+1
+0.1% +$23
USAS
3433
Americas Gold and Silver
USAS
$1.75B
$16K ﹤0.01%
16,682
-1,900
-10% -$1.93K
ACXP icon
3434
Acurx Pharmaceuticals
ACXP
$6.62M
$14K ﹤0.01%
+888
New +$26.7K
BTAI icon
3435
BioXcel Therapeutics
BTAI
$32.7M
$14K ﹤0.01%
2,378
– –
GOSS icon
3436
Gossamer Bio
GOSS
$86.8M
$14K ﹤0.01%
16,000
– –
STEM icon
3437
Stem
STEM
$48.8M
$14K ﹤0.01%
1,144
-254
-18% -$2.19K
PNST
3438
DELISTED
Pinstripes Holdings, Inc.
PNST
$14K ﹤0.01%
35,598
– –
OTLY
3439
Oatly Group
OTLY
$420M
$13K ﹤0.01%
1,003
-3
-0.3% -$44
BMTX.WS
3440
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$12K ﹤0.01%
20,104
– –
PSNY icon
3441
Polestar Automotive Holding UK
PSNY
$1.99B
$11K ﹤0.01%
357
-1
-0.3% -$36
CLSD
3442
DELISTED
Clearside Biomedical
CLSD
$10K ﹤0.01%
700
– –
EOSEW
3443
Eos Energy Enterprises Warrant
EOSEW
$30.4M
$10K ﹤0.01%
+10,000
New +$2.89K
SBEV icon
3444
Splash Beverage Group
SBEV
$2.58M
$8K ﹤0.01%
326
– –
TNXP icon
3445
Tonix Pharmaceuticals
TNXP
$205M
$8K ﹤0.01%
+228
New +$4.74K
VFF icon
3446
Village Farms International
VFF
$307M
$8K ﹤0.01%
10,133
-315
-3% -$263
VRCA icon
3447
Verrica Pharmaceuticals
VRCA
$87.4M
$8K ﹤0.01%
1,150
– –
SCWO icon
3448
374Water
SCWO
$40.6M
$7K ﹤0.01%
1,000
– –
TRUG icon
3449
TruGolf
TRUG
$1M
$7K ﹤0.01%
+21
New +$6.52K
BCTX
3450
Briacell Therapeutics
BCTX
$29.7M
$6K ﹤0.01%
75
-34
-31% -$4.08K
136 137
138
139 140

Similar funds

TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $47.7B AUM 29.41% 1-Year Est. Return

Cambridge Investment Research Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Cambridge Investment Research Advisors held 3,654 positions worth $29.9B, up 1.8% from $29.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Cambridge Investment Research Advisors's Q4 2024 filing shows 245 new, 1,618 increased, 1,517 reduced and 194 closed positions. Its largest new stake was Innovator Equity Defined Protection ETF - 6mo Apr/Oct: 337,901 shares worth $8.61M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $39.2M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q4 2024 buy was Innovator Equity Defined Protection ETF - 6mo Apr/Oct: 337,901 shares worth $8.61M.
  • Cambridge Investment Research Advisors added most to JPMorgan Ultra-Short Income ETF in Q4 2024, an estimated $103M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2024 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $39.2M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2024 Corporate Bond ETF in Q4 2024, selling an estimated $17.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 22% of its $29.9B portfolio in Q4 2024.
  • Cambridge Investment Research Advisors opened 245 new positions and closed 194 in Q4 2024.
  • Cambridge Investment Research Advisors's portfolio value rose 1.8% quarter-over-quarter to $29.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.